3rd Quarter - Report
ALERE INC. for ALERE INC.
Firm
Client
Income
—
Expenses
$152,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
FDA regulation of clinical diagnostic laboratory tests FDA regulation of prescription drugs The Generating Antibiotics Inecntives Now Act (H.R. 2182)
| Lobbyist | Covered position, as disclosed |
|---|---|
| SETH M RADUS | — |
Medicare/Medicaid MMM
Medicare payment for clinical diagnostic laboratory tests The Patient Protection and Affordable Care Act (P.L. 111-148): Implementation of provisions on Accountable Care Organizations and "prevention fund".
| Lobbyist | Covered position, as disclosed |
|---|---|
| SETH M RADUS | — |
Medical/Disease Research/Clinical Labs MED
Development of new and innovative clinical diagnostic laboratory tests.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SETH M RADUS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.